A panelist discusses how obtaining a Clinical Laboratory Improvement Amendments (CLIA) waiver is an essential regulatory step for pharmacies to perform point-of-care testing, followed by credentialing with payers to receive reimbursement for these services.
Regulatory Framework and Credentialing
Main Discussion Topics:
Key Points for Physicians:
Notable Insights:
Clinical Significance:
Although regulatory and credentialing processes require an initial investment of time, they establish the foundation for pharmacy-based clinical services that can expand health care access points and create sustainable revenue streams through formalized medical billing pathways.
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.